Bill > H1567

This bill addresses insulin administration in group home facilities for individuals with developmental disabilities by establishing new guidelines and protections for direct-support professionals (DSPs) and relatives who help clients manage their insulin. The bill defines a direct-support professional as a paid caregiver who provides services to help clients with daily living activities and community integration. Under the new law, DSPs and relatives can administer insulin to clients in group home facilities if they complete specific training provided by a qualified healthcare professional, such as a registered nurse or physician. The group home facility must develop comprehensive policies for insulin administration, including maintaining accurate dosage records, coordinating administration to prevent duplications, establishing emergency procedures, and certifying individuals who can administer insulin. The bill provides legal immunity for group home facilities, DSPs, and relatives from civil liability when insulin is administered according to these guidelines. Additionally, the bill clarifies that insulin administration includes sliding scale insulin therapy, which involves calculating and administering insulin doses based on current blood glucose levels using insulin pens or syringes. The legislation aims to enhance care and support for individuals with developmental disabilities by allowing trained non-medical personnel to assist with critical medical needs. The bill will take effect on July 1, 2025.

Health and Social Services

Human Services Subcommittee (House)

https://www.flsenate.gov/Session/Bill/2025/1567